AddLife acquires BioCat GmbH

BioCat is a specialized distributor of products and services for research in Life Science and has sales of approximately SEK 90 million

AddLife acquires O’Flynn Medical

AddLife acquires O’Flynn Medical as add-on to HC21. O’Flynn Medical has operations in Ireland and a turnover of approximately SEK 64 million.

AddLife acquires MBA Incorporado

a leading Spanish orthopaedic and trauma surgery business with a turnover of approximately EUR 67 million and 285 employees

A successful quarter

Interim Report 2022

We start 2022 with a strong first quarter, where sales increased by 49 percent to SEK 2,579 million and EBITA increased by 34 percent to SEK 435 million, resulting in an EBITA margin of 16.9 percent. This growth comes mainly from our acquisitions and the strong expansion in Europe in recent years.

Donation to Ukraine

AddLife has today donated medical devices for critical care to Ukraine at an approximated amount of SEK 7 million. The donation has been made in coordination with the Ukraine embassy in Stockholm and Ukraine Ministry of Foreign Affairs to meet specified needs from their health department.

The products are currently being transported to the border between Poland and Ukraine. The initiative is a collaboration between the group companies Mediplast (Sweden) and Healthcare 21 (UK & Ireland) with support from Biomedica Medizinprodukte´s (Austria) local office in Poland.

We want to recognize the strong engagement and extra work by our employees for making this initiative happen.


Labtech offers products, solutions and a broad range of services in diagnostics, biomedical research and laboratory analysis.



Medtech offers products, solutions and services in medtech and home care.



We develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.



Our vision is to improve people's lives, for example by sponsoring: